These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 15350366)
21. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer. Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232 [TBL] [Abstract][Full Text] [Related]
22. Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors. Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tokuda M Int J Oncol; 2002 Aug; 21(2):315-20. PubMed ID: 12118327 [TBL] [Abstract][Full Text] [Related]
23. [Expressions of Cx43 and Skp2 in epithelial ovarian tumor and their clinical significances]. Hu YQ; Liu YJ Ai Zheng; 2005 Jan; 24(1):104-9. PubMed ID: 15642212 [TBL] [Abstract][Full Text] [Related]
25. Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer. Borgoño CA; Kishi T; Scorilas A; Harbeck N; Dorn J; Schmalfeldt B; Schmitt M; Diamandis EP Clin Cancer Res; 2006 Mar; 12(5):1487-93. PubMed ID: 16533772 [TBL] [Abstract][Full Text] [Related]
26. Absence of estrogen receptor-alpha expression in human ovarian clear cell adenocarcinoma compared with ovarian serous, endometrioid, and mucinous adenocarcinoma. Fujimura M; Hidaka T; Kataoka K; Yamakawa Y; Akada S; Teranishi A; Saito S Am J Surg Pathol; 2001 May; 25(5):667-72. PubMed ID: 11342781 [TBL] [Abstract][Full Text] [Related]
27. [Association of HER-2/neu expression with prognosis of gastric cancer]. Chen B; Luo RC; Cui F; Qian XY Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):344-7. PubMed ID: 16546744 [TBL] [Abstract][Full Text] [Related]
28. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study. Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC; Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296 [TBL] [Abstract][Full Text] [Related]
29. [Assessment of prognostic factors in common ovarian tumors of varying malignancy]. Demeter A; Várkonyi T; Csapó Z; Szánthó A; Oláh J; Papp Z Magy Onkol; 2004; 48(3):259-65. PubMed ID: 15520877 [TBL] [Abstract][Full Text] [Related]
30. HER-2/neu oncogene amplification in stage I and stage III ovarian papillary serous carcinoma. Afify AM; Werness BA; Mark HF Exp Mol Pathol; 1999 Jun; 66(2):163-9. PubMed ID: 10409445 [TBL] [Abstract][Full Text] [Related]
31. [Correlation of hK6 expression with clinicopathological features and prognosis in epithelial ovarian cancer]. Hu CJ; Zhang F; Chen YJ; Sun XM; Zheng JF Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):520-3. PubMed ID: 19950700 [TBL] [Abstract][Full Text] [Related]
32. Amplification of c-erbB2 oncogene: a major prognostic indicator in uterine serous papillary carcinoma. Santin AD; Bellone S; Van Stedum S; Bushen W; Palmieri M; Siegel ER; De Las Casas LE; Roman JJ; Burnett A; Pecorelli S Cancer; 2005 Oct; 104(7):1391-7. PubMed ID: 16116605 [TBL] [Abstract][Full Text] [Related]
33. Impact of Her-2 Neu overexpression on outcome of elderly women treated with wide local excision and breast irradiation for early stage breast cancer: an exploratory analysis. Poltinnikov IM; Rudoler SB; Tymofyeyev Y; Kennedy J; Anne PR; Curran WJ Am J Clin Oncol; 2006 Feb; 29(1):71-9. PubMed ID: 16462507 [TBL] [Abstract][Full Text] [Related]
34. Role of immunohistochemical identification of Her-2/neu and detection of variability in overexpression in pancreatic carcinoma. Koka V; Potti A; Koch M; Fraiman G; Mehdi S; Levitt R Anticancer Res; 2002; 22(3):1593-7. PubMed ID: 12168842 [TBL] [Abstract][Full Text] [Related]
35. Long-term follow-up and prognostic factor analysis in clear cell adenocarcinoma of the ovary. Mizuno M; Kikkawa F; Shibata K; Kajiyama H; Ino K; Kawai M; Nagasaka T; Nomura S J Surg Oncol; 2006 Aug; 94(2):138-43. PubMed ID: 16847906 [TBL] [Abstract][Full Text] [Related]
36. TTF-1 expression in primary ovarian epithelial neoplasia. Graham AD; Williams AR; Salter DM Histopathology; 2006 May; 48(6):764-5. PubMed ID: 16681695 [No Abstract] [Full Text] [Related]
38. Lack of prognostic significance of HER-2/neu in early epithelial ovarian cancer. Sueblinvong T; Manchana T; Khemapech N; Triratanachat S; Termrungruanglert W; Tresukosol D Asian Pac J Cancer Prev; 2007; 8(4):502-6. PubMed ID: 18260719 [TBL] [Abstract][Full Text] [Related]
39. Long-term prognostic significance of HER-2/neu in untreated node-negative breast cancer depends on the method of testing. Schmidt M; Lewark B; Kohlschmidt N; Glawatz C; Steiner E; Tanner B; Pilch H; Weikel W; Kölbl H; Lehr HA Breast Cancer Res; 2005; 7(2):R256-66. PubMed ID: 15743506 [TBL] [Abstract][Full Text] [Related]
40. Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer. Ferrandina G; Ranelletti FO; Lauriola L; Fanfani F; Legge F; Mottolese M; Nicotra MR; Natali PG; Zakut VH; Scambia G Gynecol Oncol; 2002 May; 85(2):305-10. PubMed ID: 11972392 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]